Thus, similar studies should be performed to profile the substrates of HUWE1, COP1, PIRH2, and the other E3s upstream of p53 in a proteome-wide manner, so that the potential of these E3s as anti-cancer therapeutic targets could be assessed and established. Here, TP53 is linked to cancer.